BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 17, 2003
View Archived Issues
Novel dopamine autoreceptor partial agonists designed at Wyeth
Read More
Millennium claims novel CCR5 modulators and their use in HIV infection
Read More
New IL-4 production inhibitors identified by Mitsubishi Pharma researchers
Read More
Dual TXA2/5-HT2 antagonists prepared and tested by Servier research team
Read More
Antiallergic benzopyrans in early development at Japanese lab
Read More
Ono presents novel PPARalpha/PPARgamma agonists for diabetes and lipoprotein disorders
Read More
Morishita Jintan claims plant extracts with antidiabetic activity
Read More
Evidence of antiretroviral activity reported for amdoxovir in treatment-experienced patients
Read More
Lower serum melatonin levels reported in patients with HIV-1 infection
Read More
Good pregnancy rates reported with ganirelix in IVF/ICSI
Read More
Pharmacokinetics, efficacy and safety data presented for enfuvirtide
Read More
New data on the efficacy and safety of emtricitabine therapy in HIV infection
Read More
Genesis Bioventures and Innathera sign business combination agreement
Read More
AstraZeneca submits data to support Crestor NDA
Read More
Merck and MerLion enter drug discovery alliance
Read More
Albany Molecular Research enters natural products collaboration with Lilly
Read More
Phase II trial commences for Aquavan
Read More
BioMS makes plans for phase I trial of HYC-750
Read More
Endovasc sponsors preliminary Liprostin study
Read More
Phase I StemEx trial begins patient enrollment
Read More
Repligen studies triacetyluridine for mitochondrial disease in new phase I/II trial
Read More
FluINsure generates encouraging data in challenge study
Read More
DX-88 granted orphan drug designation by FDA
Read More
CAT reports first-quarter update
Read More
NBI-42902 well tolerated and effective in postmenopausal women
Read More
Nonpeptide GnRH antagonist shows rapid, long-lasting oral activity in humans
Read More